Literature DB >> 8169594

Measurement of calcium transients and slow calcium current in myotubes.

J García1, K G Beam.   

Abstract

The purpose of this study was to characterize excitation-contraction (e-c) coupling in myotubes for comparison with e-c coupling of adult skeletal muscle. The whole cell configuration of the patch clamp technique was used in conjunction with the calcium indicator dye Fluo-3 to study the calcium transients and slow calcium currents elicited by voltage clamp pulses in cultured myotubes obtained from neonatal mice. Cells were held at -80 mV and stimulated with 15-20 ms test depolarizations preceded and followed by voltage steps designed to isolate the slow calcium current. The slow calcium current had a threshold for activation of about 0 mV; the peak amplitude of the current reached a maximum at 30 to 40 mV a and then declined for still stronger depolarizations. The calcium transient had a threshold of about -10 mV, and its amplitude increased as a sigmoidal function of test potential and did not decrease again even for test depolarizations sufficiently strong (> or = 50 mV) that the amplitude of the slow calcium current became very small. Thus, the slow calcium current in myotubes appears to have a negligible role in the process of depolarization-induced release of intracellular calcium and this process in myotubes is essentially like that in adult skeletal muscle. After repolarization, however, the decay of the calcium transient in myotubes was very slow (hundreds of ms) compared to adult muscle, particularly after strong depolarizations that triggered larger calcium transients. Moreover, when cells were repolarized after strong depolarizations, the transient typically continued to increase slowly for up to several tens of ms before the onset of decay. This continued increase after repolarization was abolished by the addition of 5 mM BAPTA to the patch pipette although the rapid depolarization-induced release was not, suggesting that the slow increase might be a regenerative response triggered by the depolarization-induced release of calcium. The addition of either 0.5 mM Cd2+ + 0.1 mM La3+ or the dihydropyridine (+)-PN 200-110 (1 microM) reduced the amplitude of the calcium transient by mechanisms that appeared to be unrelated to the block of current that these agents produce. In the majority of cells, the decay of the transient was accelerated by the addition of the heavy metals or the dihydropyridine, consistent with the idea that the removal system becomes saturated for large calcium releases and becomes more efficient when the size of the release is reduced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169594      PMCID: PMC2216853          DOI: 10.1085/jgp.103.1.107

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  25 in total

1.  Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle.

Authors:  E Rios; G Brum
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

2.  Measurement of calcium transients in frog muscle by the use of arsenazo III.

Authors:  R Miledi; I Parker; G Schalow
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-08-22

3.  Primary structure of the receptor for calcium channel blockers from skeletal muscle.

Authors:  T Tanabe; H Takeshima; A Mikami; V Flockerzi; H Takahashi; K Kangawa; M Kojima; H Matsuo; T Hirose; S Numa
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

4.  Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.

Authors:  V Flockerzi; H J Oeken; F Hofmann; D Pelzer; A Cavalié; W Trautwein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

5.  Calcium channel activity in a purified dihydropyridine-receptor preparation of skeletal muscle.

Authors:  J S Smith; E J McKenna; J J Ma; J Vilven; P L Vaghy; A Schwartz; R Coronado
Journal:  Biochemistry       Date:  1987-11-03       Impact factor: 3.162

6.  Simultaneous measurements of Ca2+ currents and intracellular Ca2+ concentrations in single skeletal muscle fibers of the frog.

Authors:  G Brum; E Stefani; E Rios
Journal:  Can J Physiol Pharmacol       Date:  1987-04       Impact factor: 2.273

7.  Intramembrane charge movement and calcium release in frog skeletal muscle.

Authors:  W Melzer; M F Schneider; B J Simon; G Szucs
Journal:  J Physiol       Date:  1986-04       Impact factor: 5.182

8.  Twitches in the presence of ethylene glycol bis( -aminoethyl ether)-N,N'-tetracetic acid.

Authors:  C M Armstrong; F M Bezanilla; P Horowicz
Journal:  Biochim Biophys Acta       Date:  1972-06-23

9.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

10.  The removal of myoplasmic free calcium following calcium release in frog skeletal muscle.

Authors:  W Melzer; E Ríos; M F Schneider
Journal:  J Physiol       Date:  1986-03       Impact factor: 5.182

View more
  36 in total

1.  Involvement of the carboxy-terminus region of the dihydropyridine receptor beta1a subunit in excitation-contraction coupling of skeletal muscle.

Authors:  M Beurg; C A Ahern; P Vallejo; M W Conklin; P A Powers; R G Gregg; R Coronado
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Differential regulation of skeletal muscle L-type Ca2+ current and excitation-contraction coupling by the dihydropyridine receptor beta subunit.

Authors:  M Beurg; M Sukhareva; C A Ahern; M W Conklin; E Perez-Reyes; P A Powers; R G Gregg; R Coronado
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

3.  Excitation--contraction uncoupling by a human central core disease mutation in the ryanodine receptor.

Authors:  G Avila; J J O'Brien; R T Dirksen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation.

Authors:  Michael Rubart; Mark H Soonpaa; Hidehiro Nakajima; Loren J Field
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

5.  Functional interaction of CaV channel isoforms with ryanodine receptors studied in dysgenic myotubes.

Authors:  Ralph Peter Schuhmeier; Elodie Gouadon; Daniel Ursu; Nicole Kasielke; Bernhard E Flucher; Manfred Grabner; Werner Melzer
Journal:  Biophys J       Date:  2004-12-30       Impact factor: 4.033

6.  Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop.

Authors:  C M Wilkens; N Kasielke; B E Flucher; K G Beam; M Grabner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

7.  Alpha2delta1 dihydropyridine receptor subunit is a critical element for excitation-coupled calcium entry but not for formation of tetrads in skeletal myotubes.

Authors:  Marcin P Gach; Gennady Cherednichenko; Claudia Haarmann; Jose R Lopez; Kurt G Beam; Isaac N Pessah; Clara Franzini-Armstrong; Paul D Allen
Journal:  Biophys J       Date:  2008-01-11       Impact factor: 4.033

8.  Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.

Authors:  Iwona Ruchala; Vanessa Cabra; Ernesto Solis; Richard A Glennon; Louis J De Felice; Jose M Eltit
Journal:  Cell Calcium       Date:  2014-04-27       Impact factor: 6.817

9.  Purification and characterization of ryanotoxin, a peptide with actions similar to those of ryanodine.

Authors:  J Morrissette; M Beurg; M Sukhareva; R Coronado
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

10.  Molecular origin of the L-type Ca2+ current of skeletal muscle myotubes selectively deficient in dihydropyridine receptor beta1a subunit.

Authors:  C Strube; M Beurg; M Sukhareva; C A Ahern; J A Powell; P A Powers; R G Gregg; R Coronado
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.